Everybody is innovating with the “next big thing,” yet nothing is as revolutionary or game-changing as the marketers want you to believe. Often, it’s just more of the same, which is exactly how I feel whenever someone pitches yet another fitness tracker or personal health record.
Over the weekend, we saw some pushback in the form of humor.
Saturday’s “Dilbert” comic addressed smart watches, though it actually poked fun at the skepticism.
The storyline continued Monday.
This Cars.com commercial debuted in March, but it has been running quite a bit in the last few days. It put down someone’s app that promised to “revolutionize” an industry as just another “me-too” attempt.
[youtube http://www.youtube.com/watch?v=NJpk6upQHcE]
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
“Cancel the IPO,” the stunned presenter said. Even though Evolent Health just had a successful IPO and Fitbit, Teladoc and Mindbody are planning on going public soon, take these jokes as a warning. Things don’t always work like you expect them to, and sometimes “new” ideas aren’t new at all.
